Bulk Suggestion
Bulk ID:
braviboron/05.20.25-02:07AM
Accepted at: Jun, 06, 2025
12:05 a.m.
Author:
braviboron
Related Deck:
1675118865074
Accepted
Rationale for new note
Psoriasis. This completes the PassMed content, though I used eTG as the main source where possible.
Text
What percentage of patients with psoriasis develop psoriatic arthropathy?
{{c1::Around 10%}}
{{c1::Around 10%}}
Text
What percentage of patients with <b>psoriasis </b>develop <u>psoriatic arthropathy</u>?<br><br>{{c1::Around 10%}}
Extra
Empty field
Extra
Personal Notes
Empty field
Personal Notes
Missed Questions
Empty field
Missed Questions
Oxford Handbook
Empty field
Oxford Handbook
First Aid
Empty field
First Aid
AMBOSS
Empty field
AMBOSS
eTG Complete
eTG Complete
<img src="1635434b32327f0044275c7988fc09c5.webp">
Talley & O'Connor
Empty field
Talley & O'Connor
Additional Resources
eTG - Psoriatic arthritis https://app-tg-org-au.ap1.proxy.openathens.net/viewTopic?etgAccess=true&guidelinePage=Dermatology&topicfile=c_DMG_Considerations-in-the-use-of-topical-corticosteroids_topic_1&guidelinename=auto§ionId=c_DMG_Psoriasis_topic_3#c_DMG_Psoriasis_topic_3 Published/Amended February 2025, Accessed 20 May 2025
Additional Resources
eTG - Psoriatic arthritis <a href="https://app-tg-org-au.ap1.proxy.openathens.net/viewTopic?etgAccess=true&guidelinePage=Dermatology&topicfile=c_DMG_Considerations-in-the-use-of-topical-corticosteroids_topic_1&guidelinename=auto%C2%A7ionId=c_DMG_Psoriasis_topic_3#c_DMG_Psoriasis_topic_3">https://app-tg-org-au.ap1.proxy.openathens.net/viewTopic?etgAccess=true&guidelinePage=Dermatology&topicfile=c_DMG_Considerations-in-the-use-of-topical-corticosteroids_topic_1&guidelinename=auto&sectionId=c_DMG_Psoriasis_topic_3#c_DMG_Psoriasis_topic_3</a> Published/Amended February 2025, Accessed 20 May 2025
Source
Psoriasis. PassMedicine. Accessed May 2025. https://passmedicine.com
Source
Psoriasis. PassMedicine. Accessed May 2025. <a href="https://passmedicine.com/menu.php?revise=all">https://passmedicine.com</a>
One by one
Empty field
One by one
Tags
#Malleus_CM::#eTG_Complete::Rheumatology::Spondyloarthritis::Psoriatic_arthritis
#Malleus_CM::#Resources_by_Rotation::Dermatology
#Malleus_CM::#Resources_by_Rotation::General_Practice
#Malleus_CM::#Resources_by_Rotation::Internal_Medicine::General_Medicine
#Malleus_CM::#Resources_by_Rotation::Internal_Medicine::Immunology
#Malleus_CM::#Resources_by_Rotation::Internal_Medicine::Rheumatology
#Malleus_CM::#Resources_by_Rotation::Paediatrics
#Malleus_CM::#Resources_by_Rotation::Surgery::Orthopaedic_Surgery
#Malleus_CM::#Subjects::Dermatology::03_Psoriasis::Psoriasis::11_Complications/Prognosis
#Malleus_CM::#Subjects::Neurology_&_Special_Senses::04_Spinal_Cord_Disorders::*General::Back_Pain_Differentials::Inflammatory_Causes
#Malleus_CM::#Subjects::Orthopaedics_&_Rheumatology::02_Pathology::02_Joint::Seronegative_Spondyloarthritis::Psoriatic_Arthritis::03_Risk_Factors
#Malleus_CM::#Subjects::Paediatrics::02_Dermatology::Psoriasis::11_Complications/Prognosis